Pharm management of HTN I - Lee Flashcards

1
Q

BP aka MAP equation

A

BP = CO x TPR

  • increase bp by increasing CO and/or TPR
  • vascular tone also affects TPR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CO equation

A

CO = HR x SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

effects of angiotensin II

A
  1. arteriole smooth muscle vasoconstriction

2. aldosterone release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ACE

A

converts ang I to angII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

renin

A

converts angiotensinogen to angI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ACE inhibitors

A
  • prevent conversion of angI to angII
  • prevent breakdown of bradykinin (vasodilator), which stimulates lung irritation
  • for HTN, heart failure, diabetic neuropathy
  • teratogen for pregnancy***
  • not for when renal perfusion is low in stenosis (exacerbates issue)*

adverse effects
-acute renal failure (too low BP and stenosis), hyperkalemia from aldosterone suppression, dry cough, angioedema, severe hypotension in hypovolemic patients, skin rash, and altered/loss taste**

drug interactions

  • hyperkalemia if used with K+ supplements/diuretics
  • NSAIDs blocking bradykinin mediated vasodilation
  • NSAIDs also reducing prostaglandins –> vasoconstriction decreasing renal blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

captopril, enalapril, fosinopril, lisinopril

A
  • all are ACE inhibitors –> preventing conversion of angI to angII
  • prevent inactivation bradykinin
  • all given orally
  • all excreted by kidney –> renal damage requires dose adjustment
  • all have same indications –> HTN, heart failure, diabetic neuropathy**
  • same contraindications –> pregnancy (teratogenic), bilateral renovascular disease, hyperkalemia
  • only half life changes**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

captopril

A
  • not prodrug**
  • half life = 2hr.**
  • have to give multiple doses per day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

enalapril

A
  • prodrug –> dicarboxyl containing

- half life = 11 hr. ** (better for compliance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

fosinopril

A
  • prodrug –> phosphorous containing group
  • half life = 11.5 hr. **
  • excreted in urine and bile*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

lisinopril

A
  • prodrug –> phosphorous containing

- half life = 12 hr. **

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

angiotensin II receptor blockers (ARB)

A
  • block AT1 receptors* for angII
  • no effect on bradykinin metabolism** - more selective to angiotensin
  • oral bioavailability usually low (<50%)

indications –> HTN
-can be combined with other drugs

contraindications –> 2nd and 3rd trimester of pregnancy (can reduce fetal renal function causing neonatal death)

side effects –> cough and angioedema, but less than ACE inhibitors

drug interactions

  • with ACEI, sacubitril/valsartan increases risk of serious angioedema (more common in african americans*)
  • K-sparing diuretics or K supplements –> hyperkalemia
  • NSAIDs –> worsen renal failure
  • lithium toxicity*

FETAL TOXICITY**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

losartan, candesartan, valsartan

A
  • all are ARB –> block AT1 receptors** (block angII activity)
  • same indications –> HTN, heart failure, diabetic neuropathy, intolerance to ACE inhibitors (angioedema, cough)*
  • same contraindications –> pregnancy, use with aliskiren in diabetic patients*
  • adverse effects –> dry cough, hyperkalemia, skin rash, hypotension, altered taste*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

losartan

A
  • for sure indicated with diabetic patients

- go to drug if patient has angioedema or cough**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

candesartan

A

-contraindicated in breast feeding like the others**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

valsartan

A

-indicated in left ventricular dysfunction or failure after MI*****

17
Q

ARB + Neprilysin inhibitor

A
  • double effects if combined with other drugs
  • Sacubitril (neprilysin inhibitor) combined with valsartan (ARB)**
  • sacubitril –> decreases vasoconstriction, Na+ retention, and maladaptive remodeling
  • valsartan –> inhibits angII effects and release of aldosterone
  • indications –> treat heart failure with reduced ejection fraction** (HFrEF) –> greater effect with drug combination (reduced death from CV causes and slowed progression of HF)
  • contraindications –> pregnancy**

adverse effects –> hypotension, hyperkalemia, cough, angioedema*

drug interactions –> same as ARB

18
Q

what is neprilysin?

A
  • neutral endopeptidase that degrades vasoactive & natriuretic peptides, bradykinin & adrenomedullin
  • metabolizes ANP, BNP, CNP
19
Q

aliskiren** - renin inhibitors

A
  • binds renin & inhibits cleavage of angI from angiotensinogen**
  • for HTN (not drug of 1st choice bc expensive)*
  • not used with other ACE inhibitors or ARB in diabetics
  • use for someone with problems with ACE inhibitors**
  • side effects of fetal/neonatal death in 2nd/3rd trimester
  • GI adverse side effects**
20
Q

aliskiren + hydrochlorothiazide (diuretic)

A
  • combination therapy
  • for patient whos BP is not controlled well enough by either of these drugs alone or if it is controlled well with hydrochlorothiazide but has hypokalemia
  • not indicated for initial therapy
  • discontinue if pregnant